EC Number   |
Posttranslational Modification |
Reference |
|---|
   3.2.1.62 | glycoprotein |
- |
208744, 208745, 208747, 208753 |
| 3.2.1.62 | glycoprotein |
17% carbohydrate content, consisting of galactose, mannose, fucose, N-acetylglucosamine |
208761 |
| 3.2.1.62 | glycoprotein |
endo H treatment |
208754 |
| 3.2.1.62 | glycoprotein |
mature LPH O- and N-glycosylated, no sialic acids |
208749 |
| 3.2.1.62 | glycoprotein |
membrane anchored type I glycoprotein |
756114 |
| 3.2.1.62 | glycoprotein |
processing of enzyme to a complex glycosylated protein increases in presence of pro-region |
656110 |
| 3.2.1.62 | glycoprotein |
various modified glycoforms do not affect the transport from the Golgi to the cell surface |
208748 |
| 3.2.1.62 | proteolytic modification |
oral doses of insulin-like growth factor I increase the processing efficiency of pro-enzyme but do not affect enzyme activity |
656599 |
| 3.2.1.62 | proteolytic modification |
precursor form of 200000-220000 Da |
656061 |
| 3.2.1.62 | proteolytic modification |
pro-enzyme is cleaved in trans-Golgi network between Arg734 and Leu735, pro-region of enzyme is an intramolecular chaperone, analysis of processing and folding |
656110 |
